Contact this trialFirst, we need to learn more about you.
SGLT2 Inhibitor
Empagliflozin for Type 1 Diabetes
Recruiting2 awardsPhase 4
Montréal, Quebec
This trial aims to see if taking empagliflozin along with an automated insulin delivery system can help improve blood sugar control in people with type 1 diabetes who are not meeting their target glucose
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.